Caribou Biosciences (CRBU) Receivables - Other (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Receivables - Other data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Receivables - Other fell 21.64% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 21.64% YoY) and the FY2025 annual result came in at $1.0 million, down 44.97% from the prior year.
• Receivables - Other advanced to $1.4 million in Q1 2026 per CRBU's latest filing, from $1.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $3.1 million in Q2 2022 and bottomed at $860000.0 in Q3 2025.
• The 5-year median for Receivables - Other is $1.7 million (2024), against an average of $1.8 million.
• The widest annual swing landed in 2022, when Receivables - Other plunged 59.16%; it then climbed 15.65% in 2024.
• Tracing CRBU's Receivables - Other over 5 years: stood at $2.2 million in 2022, then rose by 1.74% to $2.3 million in 2023, then declined by 20.03% to $1.8 million in 2024, then slumped by 44.97% to $1.0 million in 2025, then jumped by 43.64% to $1.4 million in 2026.
• Per Business Quant, the three latest CRBU Receivables - Other figures stand at $1.4 million (Q1 2026), $1.0 million (Q4 2025), and $860000.0 (Q3 2025).

Peer Comparison